Dataset: Expression profiles of cell populations purified from human CRC (3 ways)
The survival of isolated metastatic cells and expansion into macroscopic tumour has been recognized as a limiting step for metastasis...
The survival of isolated metastatic cells and expansion into macroscopic tumour has been recognized as a limiting step for metastasis formation in several cancer types yet the determinants of this process remain largely uncharacterized. In colorectal cancer (CRC), we identify a transcriptional programme in tumour-associated stromal cells, which is intimately linked to a high risk of developing recurrent disease after therapy. A large proportion of CRCs display mutational inactivation of the TGF-beta pathway but paradoxically they are characterized by high TGF-beta production. In these tumours, TGF-beta instructs a transcriptional programme in stromal cells, which confers a high risk of developing metastatic disease. We purified by FACS [CD45(+),Epcam(-)], [CD45(-) Epcam(+)] and [CD45(-) Epcam(-)] cell populations from fresh CRC samples and assessed their gene expression profiles Freshly obtained tumors from CRC patients (n=8) treated at Hospital del Mar (Barcelona, Spain) were minced and incubated with 0.1% Hyaluronidase and 0.1% Collagenase 1A. Pieces were then homogenized. Enzymatic reaction was stopped by adding 10% FBS and single cells were collected by sequential filtering. Cells were resuspended in Ammonium Chloride (0.15M) to lyse erythrocytes. Cells were stained with anti-hEpcam/TROP1-APC and anti-CD45-PE conjugated antibody. Dead cells were labeled with Propidium Iodide. Fluorescence Activated Cell Sorting (FACS) was used to separate cells.
- Species:
- human
- Samples:
- 24
- Source:
- E-GEOD-39395
- PubMed:
- 23153532
- Updated:
- Dec.12, 2014
- Registered:
- Jul.12, 2014
Sample | MARKER | INDIVIDUAL | CELL TYPE |
---|---|---|---|
GSM967338 | Epcam(-),CD45(+) | patient VIII | leukocytes |
GSM967337 | Epcam(+),CD45(-) | patient VIII | epithelial cells |
GSM967336 | Epcam(-),CD45(-) | patient VIII | stromal cells |
GSM967335 | Epcam(-),CD45(-) | patient VII | stromal cells |
GSM967334 | Epcam(+),CD45(-) | patient VII | epithelial cells |
GSM967333 | Epcam(-),CD45(+) | patient VII | leukocytes |
GSM967332 | Epcam(-),CD45(-) | patient VI | stromal cells |
GSM96733 | Epcam(-),CD45(+) | patient VI | leukocytes |
GSM967330 | Epcam(+),CD45(-) | patient VI | epithelial cells |
GSM967329 | Epcam(-),CD45(+) | patient V | leukocytes |
GSM967328 | Epcam(+),CD45(-) | patient V | epithelial cells |
GSM967327 | Epcam(-),CD45(-) | patient V | stromal cells |
GSM967326 | Epcam(-),CD45(+) | patient IV | leukocytes |
GSM967325 | Epcam(+),CD45(-) | patient IV | epithelial cells |
GSM967324 | Epcam(-),CD45(-) | patient IV | stromal cells |
GSM967323 | Epcam(-),CD45(-) | patient III | stromal cells |
GSM967322 | Epcam(-),CD45(+) | patient III | leukocytes |
GSM96732 | Epcam(+),CD45(-) | patient III | epithelial cells |
GSM967320 | Epcam(-),CD45(-) | patient II | stromal cells |
GSM967319 | Epcam(-),CD45(+) | patient II | leukocytes |
GSM967318 | Epcam(+),CD45(-) | patient II | epithelial cells |
GSM967317 | Epcam(-),CD45(-) | patient I | stromal cells |
GSM967316 | Epcam(-),CD45(+) | patient I | leukocytes |
GSM967315 | Epcam(+),CD45(-) | patient I | epithelial cells |